2011. gada 25. maijā Eiropas Direktīva 2009/136 / EK, attiecībā uz privātumu un sīkdatņu izmantošanu uz tīmekļa vietnēm, kas stājās spēkā. Par sīkdatņu izmantošana ir būtiska, lai mūsu mājas lapā, piemēram, mūsu kuģošanas līdzekļus un pakalpojumus, un, lai tos izmantot sīkdatnes, ir noteikti. Jūs varat dzēst vai bloķēt visas sīkdatnes no šīs vietnes, taču neviena daļas vietā strādās.

Bioniche Pharma

Bioniche Pharma

Bioniche Pharma is a global manufacturer of injectable pharmaceutical products serving a variety of niche markets, with expertise in injectable hyaluronic acid products for use in orthopedics, rheumatology, urology and dermatology. The company's growth is fueled by an internal development pipeline and an aggressive acquisition strategy for products. Bioniche Pharma was acquired in September 2010 by Mylan Inc. (Nasdaq; MYL), a Fortune 500 company that ranks as one of the world's leading generic and specialty pharmaceuticals companies, providing products to customers in more than 140 countries and territories. Mylan's acquisition of Bioniche Pharma provides the company with immediate entry into the North American injectables market and a platform for the commercialization of future biosimilar product offerings.

IEEJA VEIKALĀ

We ship Worldwide
PayPal Logo